Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anlon HealthcareNSE:AHCL +1.26%23 Current Ratio is 0.00 as of Jun. 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 996 Drug Manufacturers companies, Anlon Healthcare ranks better than 66.87% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Anlon Healthcare's current ratio for the quarter that ended in Jun. 2026 was 0.00.
Anlon Healthcare has a current ratio of 0.00. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Anlon Healthcare has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Anlon Healthcare's Current Ratio or its related term are showing as below:
NSE:AHCL'
s Current Ratio Range Over the Past 10 Years
Min: 1.85 Med: 2.01 Max: 4.65
Current: 2.87
During the past 5 years, Anlon Healthcare's highest Current Ratio was 4.65. The lowest was 1.85. And the median was 2.01.
NSE:AHCL's Current Ratio is ranked better than 66.87% of 996
companies
in the Drug Manufacturers industry
Industry Median: 1.965
vs NSE:AHCL: 2.87
Anlon Healthcare (NSE:AHCL) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Anlon Healthcare Current Ratio Related Terms
Anlon Healthcare Current Ratio Historical Data
* Premium members only.
The historical data trend for Anlon Healthcare's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Anlon Healthcare's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anlon Healthcare Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Anlon Healthcare's Current Ratio distribution charts can be found below:
* The bar in red indicates where Anlon Healthcare's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anlon Healthcare (NSE:AHCL) has a Current Ratio of 0.00 as of Jun. 2026. Over the past decade, Anlon Healthcare's Current Ratio has ranged from 1.85 to 4.65. According to the industry distribution chart, Anlon Healthcare ranks #330 out of 996 companies in the Drug Manufacturers industry, placing it in the top 33.1%.
Is Anlon Healthcare's Current Ratio too high?
Anlon Healthcare's current Current Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 1.85 to a high of 4.65. Based on the distribution chart, Anlon Healthcare ranks #330 out of 996 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Anlon Healthcare has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Current Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Anlon Healthcare ranks #330 out of 996 companies for Current Ratio. This puts Anlon Healthcare in the upper half of its industry. The industry median Current Ratio is 1.97. Historically, Anlon Healthcare's own Current Ratio has ranged from 1.85 to 4.65 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 1.97, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anlon Healthcare's current Current Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Current Ratio of 0.00. The current Current Ratio is 0.00. Anlon Healthcare's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Current Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
23GF Score
Get the complete analysis for NSE:AHCL
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AHCL has been successfully added to your 
